| scholarly article | Q13442814 |
| P2093 | author name string | D A Thorley-Lawson | |
| K P Mann | |||
| P2860 | cites work | Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene | Q28142488 |
| Epstein-Barr virus superinduces a new human b cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts | Q28264882 | ||
| Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation | Q34386338 | ||
| Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes | Q36335723 | ||
| Epstein-Barr virus susceptibility of normal human B lymphocyte populations | Q36348358 | ||
| Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA | Q36416749 | ||
| Flow cytometric estimation of DNA and RNA content in intact cells stained with hoechst 33342 and pyronin Y | Q36590194 | ||
| A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection | Q37577729 | ||
| A New Approach to the Study of Human B Lymphocyte Function Using an Indirect Plaque Assay and a Direct B Cell Activator | Q37997650 | ||
| Epstein-barr virus-induced transformation of human leukocytes after cell fractionation | Q39323315 | ||
| Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by epstein-barr virus (EBV) | Q39331761 | ||
| Epstein-Barr virus DNA in human lymphoid cell lines: In vitro conversion | Q40011422 | ||
| Induction of ebna precedes the first cellular S-phase after ebv-infection of human lymphocytes | Q40129192 | ||
| Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus | Q40155433 | ||
| Antigens on human monocytes identified by monoclonal antibodies. | Q43408490 | ||
| Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells | Q43805008 | ||
| BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus | Q44060795 | ||
| Characterization of a human B lymphocyte-specific antigen. | Q44191670 | ||
| Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein–Barr virus | Q45801050 | ||
| Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: Kinetics of EBNA expression, cellular DNA synthesis, and mitosis | Q45802455 | ||
| Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines | Q45826585 | ||
| Establishment of Lines from Normal Human Blood Leukocytes by Co-cultivation with a Leukocyte Line Derived from a Leukemic Child | Q53803559 | ||
| New cell cycle compartments identified by multiparameter flow cytometry | Q62590675 | ||
| Differential expression of cell activation markers after stimulation of resting human B lymphocytes | Q70480581 | ||
| Sorting of B lymphoblasts based upon cell diameter provides cell populations enriched in different stages of cell cycle | Q70994044 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 45-59 | |
| P577 | publication date | 1985-07-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Early events in Epstein-Barr virus infection provide a model for B cell activation | |
| P478 | volume | 162 |
| Q33756928 | A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells |
| Q43750248 | A new antigen identified by the monoclonal antibody UCHB 1 delivers a costimulatory signal to a subset of human B cells |
| Q24315666 | A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes |
| Q45834675 | Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction |
| Q33861934 | Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2 |
| Q39506948 | Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis |
| Q28281625 | B cell activation and the establishment of Epstein-Barr virus latency |
| Q44167647 | B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV). |
| Q37547616 | B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferation |
| Q40530889 | Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. |
| Q35232770 | CD23 and the Epstein-Barr virus |
| Q39539494 | Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils |
| Q41635093 | Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls |
| Q24315641 | Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes |
| Q36866420 | Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). |
| Q35831774 | Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site |
| Q45862269 | Conversion of a human B cell lymphoma line by Epstein-Barr virus is associated with increased tyrosine phosphorylation of a 50 kilodalton cytosolic protein |
| Q34343527 | Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth |
| Q42261208 | Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ. |
| Q67954617 | Detection and characterization of IgE-binding factors (IgE-BF) within supernatants of the cell line RPMI-8866, normal human sera and sera from atopic patients |
| Q39874449 | Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals |
| Q36353089 | Direct T helper-B cell interactions induce an early B cell activation antigen |
| Q40041854 | Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes. |
| Q36827022 | E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development |
| Q38304806 | EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. |
| Q90571096 | EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers |
| Q57186827 | EBNA2: A Viral Transcription Factor Essential for the Immortalization of Human B Lymphocytes by the Epstein-Barr Virus (EBV) |
| Q40181000 | EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis. |
| Q38596344 | EBV Persistence--Introducing the Virus |
| Q40594630 | EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease |
| Q45855126 | Early events in Epstein-Barr virus infection of human B lymphocytes |
| Q53491576 | Effect of TGF‐β1 on the ebv‐induced transformation of human lymphocyte cultures |
| Q43987644 | Effect of cytokines on spontaneous and allergen-induced CD23 expression, sCD23 release and Ig(E,G) synthesis from peripheral blood lymphocytes |
| Q60920702 | Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle? |
| Q34366291 | Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells |
| Q40117028 | Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2. |
| Q45788761 | Epstein-Barr virus and brain lymphomas |
| Q40475844 | Epstein-Barr virus as an agent of haematological disease. |
| Q36881880 | Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity |
| Q36806063 | Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 |
| Q35887119 | Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. |
| Q36830748 | Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin |
| Q40108807 | Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. |
| Q40040836 | Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells |
| Q36797190 | Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element |
| Q34572150 | Epstein-Barr virus: exploiting the immune system |
| Q93138401 | Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation |
| Q35029255 | Epstein-barr virus, the immune system, and associated diseases |
| Q34996836 | Epstein-barr virus: an unusual cause of cholestatic hepatitis in older adults |
| Q47203136 | Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor |
| Q46795498 | Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors. |
| Q36403991 | Expression, Structure, and Function of the CD23 Antigen |
| Q70066404 | Functional interaction between B cell subpopulations defined by CD23 expression |
| Q43851374 | Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity |
| Q40662108 | Genetic control of interleukin-4-induced activation of the human signal transducer and activator of transcription 6 signaling pathway |
| Q41047224 | Hepatitis C virus and non-Hodgkin's lymphomas |
| Q39871551 | Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus. |
| Q37731558 | Human B cells: differentiation and neoplasia |
| Q37737223 | Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses |
| Q34668808 | Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virus |
| Q39880077 | Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell |
| Q37143307 | Immunohistochemical demonstration of CD23 expression on lymphocytes in rheumatoid synovitis |
| Q92712506 | In vitro Generation of Cytotoxic T Cells With Potential for Adoptive Tumor Immunotherapy of Multiple Myeloma |
| Q41650803 | Induced CD25 expression in a human B-lymphoma cell line transfected with the Epstein-Barr virus nuclear antigen 2 gene |
| Q39873174 | Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220. |
| Q45786981 | Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis |
| Q41742638 | Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts |
| Q41655893 | Is there a unique episome in EBV transformed B cells? |
| Q68973745 | Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes |
| Q35155237 | Long-term latent murine Gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo |
| Q39480803 | Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus |
| Q36464514 | Molecular basis for Epstein-Barr virus induced pathogenesis and disease |
| Q24339640 | Molecular cloning of the lymphocyte activation marker Blast-1 |
| Q35818174 | Molecular genetic analysis of lymphoid tumors arising after organ transplantation |
| Q40098067 | Murine gammaherpesvirus M2 antigen modulates splenic B cell activation and terminal differentiation in vivo |
| Q36592640 | Nonsteroidal Anti-Inflammatory Drugs Quickly Resolve Symptoms Associated with EBV-Induced Infectious Mononucleosis in Patients with Atopic Predispositions. |
| Q22008645 | Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency |
| Q36699262 | Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells |
| Q36048272 | Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes |
| Q36889566 | Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein |
| Q36801187 | Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP |
| Q44178268 | Proliferative Response of Mononuclear Cells from HIV-Infected Patients to B-Cell Mitogens: Effects Of Lymphocyte Subset Frequency, T-Cell Defects and Prostaglandins |
| Q36688962 | Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control? |
| Q36801839 | Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. |
| Q24645714 | Structure and expression of c-fgr protooncogene mRNA in Epstein-Barr virus converted cell lines |
| Q38655812 | Structure, function, and genetics of human B cell-associated surface molecules |
| Q37117551 | Surface molecules involved in B lymphocyte function |
| Q36498200 | Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection |
| Q36581891 | The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein |
| Q36828608 | The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation |
| Q39216150 | The Epstein-Barr virus proteins |
| Q41341172 | The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells |
| Q37325443 | The curious case of the tumour virus: 50 years of Burkitt's lymphoma |
| Q52012362 | The dispersal of mucosal memory B cells: evidence from persistent EBV infection. |
| Q34545445 | The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infection |
| Q40067397 | The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA |
| Q41553353 | The role of Epstein-Barr virus in lymphoid malignancies |
| Q39483737 | Theoretical and practical aspects of B-cell activation: murine and human systems |
| Q35861192 | Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells |
| Q34427085 | Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. |
| Q36697392 | Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro |
| Q68824822 | Variant sublines of the human B-lymphoma cells Namalwa are at different stages of differentiation |
| Q36681872 | When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates |
Search more.